By Blake Brittain (Reuters) – Vanda Pharmaceuticals Inc has sued the federal government in Washington, D.C., federal court over accusations that the U.S. Food and Drug Administration passed trade secrets …
Topic:
pharmaceuticals
-
-
Nov 15 (Reuters) – Canadian wholesale trade increased by 0.1% in September from August on the higher sales in the personal and household goods subsector, and in particular pharmaceutical products, …
-
XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® Research Posters Will Be Presented LAVAL, Quebec, May 18, 2022 — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its gastroenterology business, Salix …
-
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) launches Luzsana Biotechnology™ (Luzsana)
by Your NewsLuzsana to co-develop medicines with parent company Hengrui Pharma and commercialize in North America, Europe and Japan Initial pipeline focuses on 11 high-potential programs in areas of high unmet need, …
-
NRX PHARMACEUTICALS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of NRx Pharmaceuticals, Inc. – NRXP
by Your NewsNEW ORLEANS, April 22, 2022 — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces …
-
SALIX PHARMACEUTICALS WILL PRESENT SCIENTIFIC DATA AT THE SOCIETY OF HOSPITAL MEDICINE CONVERGE 2022
by Your NewsFeatured Posters Will Include XIFAXAN® (rifaximin) and RELISTOR® (methylnaltrexone bromide) Research BRIDGEWATER, N.J., April 7, 2022 — Salix Pharmaceuticals (“Salix”), the gastroenterology business of Bausch Health Companies Inc. (NYSE/TSX: BHC) …
-
Avet Pharmaceuticals Announces Approval and Launch of Propofol Injectable Emulsion, USP
by Your NewsAvet Pharma Announces Approval and Launch of Propofol Injectable Emulsion, USP to address current market shortage Tweet this About Propofol Propofol injectable emulsion is an intravenous general anesthetic and sedation …
-
Injectable Drug Delivery Market Size to Reach USD 83.38 Billion in 2030 | Convenience and At-Home Accessibility Afforded by Injectable Pharmaceuticals are Key Factors Driving Industry Demand, Says Emergen Research
by Your NewsVANCOUVER, BC, March 30, 2022 — The global injectable drug delivery market size reached USD 15.13 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the …
-
Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launch Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg in the U.S. market USA – English USA – English
by Your News“We are pleased to collaborate with Seton Pharmaceuticals for the commercial launch of Butalbital, Acetaminophen and Caffeine Capsules in the U.S. market” stated Dhananjay Barot, Director, Senores Pharmaceuticals, Inc. “Our unfaltering …